ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Impact of Angiotensin II Type I Receptor Antibody Positivity in Highly-HLA Sensitized (HS) Patients Transplanted After Desensitization (DES).

A. Vo,1 C. Boutsicaris,1 X. Zhang,2 N. Reinsmoen,2 J. Choi,1 S. Jordan.1

1Kidney Transplant, Cedars-Sinai Medical Center, LA, CA
2HLA Laboratory, Cedars-Sinai Medical Center, LA, CA.

Meeting: 2016 American Transplant Congress

Abstract number: D14

Keywords: Antibodies, Highly-sensitized, Rejection, Sensitization

Session Information

Date: Tuesday, June 14, 2016

Session Name: Poster Session D: Antibody Mediated Rejection: Session #2

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Anti-Angiotensin II Type 1 Receptor Antibody Reduction with Proteasome Inhibitor-Based Desensitization.
  • Incidence & Impact of De Novo DSA (dnDSA) Formation on Transplant Outcomes in HLA-Sensitized (HS) Patients Transplanted After IVG+Rituximab Desensitization (DES).

Introduction: Angiotensin II type I receptor antibody (AT1R Ab) is a target for non-HLA antibodies. AT1R ab exert direct effects on endothelial and vascular smooth muscle cells. Reports of AT1R ab (+) pre-transplant is associated with higher risk for acute rejection and long term graft failure (Dragun et al. AJT 2013). However, outcomes of pre-transplant AT1R ab (+) in HS patients transplanted after desensitization is not known. Here we examined post-transplant outcomes of HS patients who were AT1R ab (+/-) pre-transplant and DSA (+/-) at-transplant. Patients & Methods: From 1/31/13 to 8/8/15, 14 HS patients {G1: AT1R ab-/DSA-, PRA>80%} v. 11 HS patients {G2: AT1R ab+/DSA-, PRA~80%} v. 24 HS patients {G3: AT1R ab-/DSA+, PRA>80%}, v. 15 HS patients {G4: AT1R ab+/DSA+, PRA~80%} underwent desensitization (DES) with IVIG (2gm/kg, maximum 140gm x2 doses) + rituximab (x1) ± PLEX (5-7sessions) and transplanted. This was a retrospective review, thus AT1R ab+/- were not used in donor allocation decision. In addition, we plan to do routine monitoring of AT1R abs once identified. Results: No differences in sex (female: range 53%-91%) or history of previous transplants (range 45%-83%) in all groups; however, DD transplant was significantly higher in G3 (100%) v. G4 (80%) (p=0.02). Though not significant, no ABMR was seen in G1 or G2; whereas ABMR was seen in 29% in G3 v. 20% in G4. Patient and graft survival was 100%/100% in G1, 2 and 4 and 100%/92% in G3, respectively. Conclusions: AT1R abs may be associated with CMR & ABMR episodes. However, in HS patients who underwent DES, DSAs appear to mediate most ABMR episodes. Thus monitoring of AT1R ab is an important facet of determining the extent of non-HLA DSA that could impact allograft outcomes. DES for AT1R ab+ alone appears to be a reasonable option for patients who are DSA- and without history of sensitizing events.

CITATION INFORMATION: Vo A, Boutsicaris C, Zhang X, Reinsmoen N, Choi J, Jordan S. Impact of Angiotensin II Type I Receptor Antibody Positivity in Highly-HLA Sensitized (HS) Patients Transplanted After Desensitization (DES). Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Vo A, Boutsicaris C, Zhang X, Reinsmoen N, Choi J, Jordan S. Impact of Angiotensin II Type I Receptor Antibody Positivity in Highly-HLA Sensitized (HS) Patients Transplanted After Desensitization (DES). [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/impact-of-angiotensin-ii-type-i-receptor-antibody-positivity-in-highly-hla-sensitized-hs-patients-transplanted-after-desensitization-des/. Accessed March 2, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.